ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma

Ma, Wenping; Bao, Zhaoshi; Qian, Zenghui; Zhang, Kenan; Fan, Wenhua; Xu, Jianbao; Ren, Changyuan; Zhang, Ying*; Jiang, Tao*哈尔滨医科大学; y
CNS Neuroscience & Therapeutics2022-6DOI: 10.1111/cns.13817
1被引7阅读
引用收藏
分享

摘要

Aims Glioblastoma (GBM) is the most common malignant brain tumor with an adverse prognosis in the central nervous system. Traditional histopathological diagnosis accompanied by subjective deviations cannot accurately reflect tumor characteristics for clinical guidance. DNA methylation plays a critical role in GBM genesis. The focus of this project was to identify an effective methylation point for the classification of gliomas, the interactions between DNA methylation and potential epigenetic targeted therapies for clinical treatments. Methods Three online (TCGA, CGGA, and REMBRANDT) databases were employed in this study. T-test, Venn analysis, univariate cox analysis, and Pearson's correlation analysis were adopted to screen significant prognostic methylation genes. Clinical samples were collected to determine the distributions of LRRFIP1 (Leucine Rich Repeat of Flightless-1 Interacting Protein) protein by immunohistochemistry assay. Kaplan-Meier survival and Cox analysis were adopted to evaluate the prognostic value of LRRFIP1. Nomogram model was used to construct a prediction model. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway were performed to explore functions and related mechanisms of LRRFIP1 in gliomas. Results Our results showed that 16 genes were negatively connected with their methylation level and correlated with clinical prognosis of GBM patients. Among them, LRRFIP1 expression showed the highest correlation with its methylation level. LRRFIP1 was highly expressed in WHO IV, mesenchymal, and IDH wild-type subtype. LRRFIP1 expression was an independent risk factor for OS (overall survival) in gliomas. Conclusion LRRFIP1 is an epigenetically regulated gene and a potential prognostic biomarker for glioma. Our research may be beneficial to evaluate clinical efficacy, assess the prognosis, and provide individualized treatment for gliomas.

学科与关键词

关键词
biomarkerDNA methylationgliomaLRRFIP1prognosis
相关
加载中…
  • Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
    Ji, Jianghuai; Zhao, Lei; Zhao, Xiaoxiao; Li, Qianpeng; An, Yi; Li, Li; Li, DongguoInternational Journal of Molecular Medicine, 2020, 46(1): 224-238.
  • TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
    Xie, Sidi; Zhang, Yunxiao; Peng, Tao; Guo, Jinglin; Cao, Yongfu; Guo, Jing; Shi, Xiaofeng; Li, Yaqin; Liu, Yawei; Qi, Songtao*; Wang, Hai*Cancer Cell International, 2021, 21(1): 148.被引 3
  • Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas
    Liu, Zhendong; Cheng, Xingbo; Lin, Shaochong; Han, Zhibin; Jin, Haoran; Luan, Zheyu; Li, Pengxu; Liang, Wenjia; Qian, Rongjun*; Gao, Yanzheng*Cellular and Molecular Neurobiology, 2023, 43(1): 409-422.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
CNS Neuroscience & Therapeutics
发表日期
2022-06
卷期
第 28 卷, 第 6 期
页码
873-883
DOI
10.1111/cns.13817
语言
ENGLISH
成果收录
SCIE
资助标注
Beijing Natural Science Foundation [7222018]; National Natural Science Foundation of China [82192894, 819723378]; public welfare development and reform pilot project of Beijing Medical Research Institute [JYY 2019-5]; CAMS Innovation Fund for Medical Sciences [2019-I2 M-5-021]; Beijing Municipal Administration of Hospitals' Mission Plan [SML20180501]; Natural Science Foundation of Beijing Municipality [JQ20030]

作者

  • M

    Ma, Wenping (第一作者)

    beijing neurosurg inst · capital med univ

  • B

    Bao, Zhaoshi

    capital med univ · beijing neurosurg inst

查看全部 9 位作者收起作者
  • Q

    Qian, Zenghui

    capital med univ · beijing neurosurg inst

  • Z

    Zhang, Kenan

    beijing neurosurg inst · capital med univ

  • F

    Fan, Wenhua

    beijing neurosurg inst · capital med univ

  • X

    Xu, Jianbao

    2 · harbin med univ

  • R

    Ren, Changyuan

    capital med univ

  • Z

    Zhang, Ying (通讯)

    capital med univ · beijing neurosurg inst

  • J

    Jiang, Tao (通讯)

    capital med univ · beijing neurosurg inst

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417